THE INTERNATIONAL SOCIETY
FOR THE
STUDY OF VULVOVAGINAL DISEASE
ABSTRACT FORM FOR PRESENTATION AT THE XXIII WORLD CONGRESS
ABSTRACT DEADLINE
Jan 1, 2015
No abstracts without final data will be accepted.
PLEASE INCLUDE THE FOLLOWING FORM ALONG WITH YOUR ABSTRACT AS A SEPARATE
SHEET:
PRESENTING AUTHOR:
ADDRESS:
AFFILIATION (NAME OF PRACTICE OR HOSPITAL):
PHONE:
FAX:
EMAIL:
PRESENTATION CONTENT: (CHECK ONE)
Abstract:
Original Study
Case Report – Series of cases
Review of Previously Published Work
Case:
Interesting case for discussion
Difficult case for review
Please submit your abstract electronically in WORD format, following the suggested format.
Cases may be submitted in Powerpoint. If submitting a case, please include a pertinent case
history, pertinent physical exam and histopathology if appropriate.
All Abstracts must use ISSVD terminology. (Bibliography is available at http://www.issvd.org
under Resources/Terminology) or CLICK HERE.
Please email the abstract and this form to Debbie Roepe at
mailto:executive.director@issvd.org?subject=Abstract Submission NY
PLEASE SIGN BELOW: (electronic signature is acceptable)
This work represents original research of which I was the primary investigator. It has not been
published prior to my presentation at the ISSVD WC.
Presenting Author’s Signature
Abstract Submission Guidelines
Abstracts for oral presentations are encouraged and welcomed. The Scientific Committee will review all
abstracts. All abstracts must be submitted electronically and written in English. Presenters are
encouraged to submit a manuscript to the Journal of Lower Genital Tract Disease following the
presentation in New York, New York.
Guidelines
Abstracts must be submitted no later than the JAN 1, 2015.
Language: English.
Size: Single US Letter (8.5 X 11) 300 word maximum.
Font: Times New Roman, single space and justified.
FONT SIZE 12
Title: Each word should begin with a capital letter except transition words. All abstracts must
contain a title.
Author: Presenting Author should be underlined. Followed by Affiliation. See sample:
First Name Last Name, Title1,2, First Name Last Name, Title3,
1Affiliation, City, State 1Affiliation, City, State 2Affiliation, City, State3
SAMPLE:
Remission and Relapse of Vulvodynia Among Prevalent and Incident Cases: A Population-Based Study
1
2
1,3
1
1,4
5 1
Barbara D Reed, MD , SD Harlow, PhD , A Sen, PhD , MA Plegue, MA , LJ Legocki, PhD , HK Haefner, MD . Department
2
of Family Medicine, University of Michigan Health Systems, Ann Arbor, MI, Department of Epidemiology, School of Public
3
Health, University of Michigan Health Systems, Ann Arbor, MI, Department of Biostatistics, School of Public Health, University
4
of Michigan Health Systems, Ann Arbor, MI, Center for Statistical Consultation & Research, University of Michigan Health
5
Systems, Ann Arbor, MI, Department of Obstetrics and Gynecology; University of Michigan Health Systems, Ann Arbor, MI.
A structured abstract of 300 words or less. The abstract should contain 4 paragraphs with the following
headings: (1) Objectives, stating the hypothesis(es) of the study; (2) Methods, including the means
for problem solving, the subjects (number and relevant characteristics), the intervention studied, and a
brief statistical analysis; (3) Results, including the outcome of the study and statistical significance;
and (4) Conclusions, stating the outcome importance.
-Write abstracts in the active voice. Express ideas briefly, clearly, and concisely.
-Use only standard abbreviations (4). Spell out all abbreviations in full preceding their first usage in the
text.
-For drugs, devices, or patented procedures, state the generic or common name, followed in
parentheses by the trade name (optional), city, and country of manufacture.
Email your abstract to mailto:executive.director@issvd.org.
If you do not receive the
confirmation e-mail within 48 hours, it indicates that the submission did not succeed and you
should try again. Submission of printed abstracts will not be accepted.